Nutriceutical Holdings (NH), parent company of Physician Recommended Nutriceuticals (PRN) and Veterinarian Recommended Solutions (VRS), and KD Pharma Group have decided to join forces through a direct investment in Nutriceutical Holdings by KD Pharma Group. KD Pharma Group will become the largest shareholder in Nutriceutical Holdings with the option to acquire the entire company.
The U.S. Patent and Trademark Office issued PRN Physician Recommended Nutriceuticals a method patent for their omega-3 nutriceutical formulation, providing further evidence that PRN’s unique and scientific omega-3 formation provides the exact nutrition for the creation of healthy tears therefore alleviating occasional dry eye symptoms. This is the second patent awarded to PRN in less than a year on its PRN Dry Eye Omega Benefits® nutriceutical product.
Newly published study available online, ahead of print, in Corneademonstrates oral consumption of re-esterified omega-3 fatty acids is an effective treatment of dry eye disease and results in a statistically significant improvement in its primary endpoint of tear osmolarity, as well as, its secondary endpoints after 12-weeks.
PRN Physician Recommended Nutriceuticals, LLC (PRN), a leading provider of nutritional supplements, today announced that the U.S. Patent and Trademark Office issued to PRN U.S. Patent No. 9,115,078 “Compositions for Improving the Quality of the Meibum Composition of Inflamed or Dysfunctional Meibomian Glands.”